Table 1 Baseline characteristics of study subjects (N = 2,203)
From: Kidney Dysfunction Impact on White Matter Hyperintensity Volume in Neurologically Healthy Adults
White Matter Hyperintensity Volume - cm3 | 2.7 | ±6.0 |
|---|---|---|
Age (year) | 56.9 | ±8.3 |
Male, n (%) | 1,215 | (55.2) |
Current Smoker, n (%) | 410 | (18.6) |
Taking Anti-hypertensive Drugs, n. (%) | 551 | (25.0) |
Taking Anti-diabetic Drugs, n. (%) | 154 | (7.0) |
Taking Anti-dyslipidemic Drugs, n (%) | 177 | (8.0) |
Taking Anti-coagulation or Anti-platelet Drugs*, n (%) | 224 | (10.2) |
Body Mass Index - kg/m2 | 24.1 | ±3.0 |
Systolic Blood Pressure - mmHg | 126.6 | ±15.8 |
Diastolic Blood Pressure - mmHg | 76.3 | ±10.6 |
Creatinine - mg/dL | 0.92 | ±0.21 |
eGFR† - ml/min/1.73 m2 | 78.0 | ±14.8 |
≥90 ml/min/1.73 m2, n (%) | 421 | (19.1) |
60–89.9 ml/min/1.73 m2, n (%) | 1610 | (73.1) |
30–59.9 ml/min/1.73 m2, n (%) | 169 | (7.7) |
<30 ml/min/1.73 m2, n (%) | 3 | (0.1) |
Urine Albumin-to-Creatinine Ratio | 0.02 | ±0.10 |
<0.03 | 2,037 | (92.5) |
≥0.03 | 166 | (7.5) |
Total Cholesterol - mg/dL | 200.7 | ±35.6 |
Low Density Lipoprotein - mg/dL | 126.3 | ±34.3 |
High Density Lipoprotein - mg/dL | 54.5 | ±13.7 |
Triglyceride - mg/dL | 119.6 | ±70.0 |
Hemoglobin A1c | 5.92 | ±0.78 |
Hypertension‡, n (%) | 859 | (39.0) |
Diabetes§, n (%) | 330 | (15.0) |
Dyslipidemia¶, n (%) | 457 | (20.7) |
